Prenexus Health Receives "No Questions" Letter from FDA for GRAS of its Xylooligosaccharide (XOS) Prebiotic

Over 70 million Americans have digestive issues and 90% of diseases can be linked in some way back to the gut. Prenexus' XOS Prebiotic selectively feeds the good bacteria at a clinically effective low dose in functional foods, beverages and supplements to provide a health benefit.

News provided by

Prenexus Health, Inc.

Aug 27, 2019, 09:00 ET

GILBERT, Ariz., Aug. 27, 2019 /PRNewswire-PRWeb/ -- Prenexus Health has received a "no questions" letter from the U.S Food and Drug Administration on its Generally Recognized as Safe notification for its xylooligosaccharide (XOS) prebiotic. Prenexus Health's XOS prebiotic is accepted for use at levels up to a 2.4 grams per day in a variety of food categories. The notice has been published on the FDA's website.

"We're pleased that the FDA had no questions related to our GRAS notification for our XOS prebiotic," said Michael Bush, chief executive officer for Prenexus Health. "This allows use of the ingredient in a range of food applications such as bars, ready-to-eat cereals and functional beverages, to name a few of the accepted categories."

Prenexus Health will be producing its XOS prebiotic from certified organic, non-GMO high-fiber sugarcane grown by the company on farms in the Imperial Valley, California. The manufacturing process, soon to be certified organic, utilizes only pure water without the need for any chemicals. Prenexus Health's XOS prebiotic will be available in the fourth quarter of 2019.

"The demand for prebiotic ingredients continues to grow," Bush said. "We're excited that our XOS prebiotic offers a low-dose, effective ingredient for food, beverage and supplement companies seeking to add the benefits of prebiotics to their products."

SOURCE Prenexus Health, Inc.